alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
## Breadcrumb

-  Home 
-  About Us 
-  NIDCD Board of Scientific Counselors 

# NIDCD Board of Scientific Counselors Roster

                    -  About the Board of Scientific Counselors 
                    -  Upcoming Meetings 

The ending date for each member's term is given next to his or her name.

## Chair

                    -  HANSEN, Marlan R., M.D. 6/30/2027  Brian F. McCabe Distinguished Chair and DEO	Departments of Otolaryngology and Neurosurgery	University of Iowa-Carver College of Medicine	Iowa City, IA 

## Board Members

                        -  OGHALAI, John, M.D. 6/30/2024  Leon J. Tiber and David S. Alpert Professor	Chair in Medicine	Chair and Professor of Otolaryngology-	Head and Neck Surgery	University of Southern California	Los Angeles, CA 
                        -  SEGAL, Rosalind, M.D., Ph.D. 6/30/2026  Professor	Department of Neurobiology and Cancer Biology	Dana-Farber Cancer Institute	Boston, MA 
                        -  SIMMONS, Dwayne D., Ph.D. 6/30/2027  Professor and Chair	Department of Biology and Department	of Psychology and Neuroscience	Baylor University	Waco, TX 
                        -  LU, Xiaowei, Ph.D. 6/30/2028  Professor	Department of Cell Biology	School of Medicine	University of Virginia	Charlottesville, VA 

                        -  HASHINO, Eri, Ph.D. 6/30/2024  Ruth C. Holton Professor and	Vice Chair for Research	Department of Otolaryngology-	Head and Neck Surgery	Indiana University School of Medicine	Indianapolis, IN 
                        -  LUMPKIN, Ellen A., Ph.D. 6/30/2026  Professor	Department of Molecular and Cellular Biology	Helen Wills Neuroscience Institute	University of California, Berkeley	Los Angeles, CA 
                        -  HELLER, Stefan, Ph.D. 6/30/2028  Edward and Amy Sewall Professor and	Associate Chair for Research	Department of Otolaryngology	Head and Neck Surgery Divisions	School of Medicine	Stanford University	Stanford, CA 

## Executive Secretary

                        -  CUNNINGHAM, Lisa, Ph.D.  Scientific Director	National Institute on Deafness and Other	Communication Disorders	National Institutes of Health	Bethesda, MD 

## 2023 Ad Hoc Consultant

                    -  GÉLÉOC, Gwenaelle, Ph.D.  Associate Professor of Otolaryngology-	Head and Neck Surgery	Harvard Medical School	Boston, MA 

September 28, 2023
EXHIBIT 31.2IEA Income Fund VIIIRule 13a-14 CERTIFICATION     I, John Kallas, certify that:     1. I have reviewed this quarterly report on Form 10-Q of IEA Income Fund VIII (the“Partnership”);     2. Based on my knowledge, this quarterly report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect to the periodcovered by this quarterly report;     3. Based on my knowledge, the financial statements, and other financial information includedin this quarterly report, fairly present in all material respects the financial condition, resultsof operations and cash flows of the Partnership as of, and for, the periods presented in thisquarterly report;     4. The other certifying officer of Cronos Capital Corp. (“CCC”), the General Partner of thePartnership, and I are responsible for establishing and maintaining disclosure controls andprocedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Partnership and wehave:          (a) designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating tothe Partnership, including its consolidated subsidiaries, is made known to us by others withinthose entities, particularly during the period in which this quarterly report is being prepared;and          (b) evaluated the effectiveness of the Partnership’s disclosure controls and procedures andpresented in this quarterly report our conclusions about the effectiveness of the disclosurecontrols and procedures, based on our evaluation; and          (c) disclosed in this quarterly report any change in the Partnership’s internal control overfinancial reporting that occurred during the Partnership’s most recent fiscal quarter (thePartnership’s fourth fiscal quarter in the case of an annual report) that has materially affected,or is reasonably likely to materially affect, the Partnership’s internal control over financialreporting.     5. CCC’s other certifying officer and I have disclosed, based on our most recent evaluationof internal control over financial reporting, to the Partnership’s auditors and the Audit Committeeof Partnership’s Board of Directors (or persons performing the equivalent function):          (a) all significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affect thePartnership’s ability to record, process, summarize and report financial information; and          (b) any fraud, whether or not material, that involves management or other employees who havea significant role in the Partnership’s internal control over financial reporting.Date: August 12, 2005/s/JOHN KALLAS
[Federal Register Volume 74, Number 101 (Thursday, May 28, 2009)]
[Notices]
[Page 25565]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-12358]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center on Minority Health and Health Disparities; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center on Minority Health and Health 
Disparities Special Emphasis Panel; RIMI (P20) Review Meeting.
    Date: June 30-July 1, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Pooks Hill Marriott, 5151 Pooks Hill Rd., Rockville, MD 
20814.
    Contact Person: Prabha L. Atreya, PhD, Chief, Office of 
Scientific Review, National Center on Minority Health and Health 
Disparities, 6707 Democracy Boulevard, Suite 800, Bethesda, MD 
20892, (301) 594-8696, <a href="/cdn-cgi/l/email-protection#ed8c999f88948c9d9fad808c8481c3838485c38a829b"><span class="__cf_email__" data-cfemail="6c0d181e09150d1c1e2c010d050042020504420b031a">[email protected]</span></a>.

    Dated: May 20, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-12358 Filed 5-27-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
[Federal Register Volume 74, Number 101 (Thursday, May 28, 2009)]
[Notices]
[Page 25610]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-12422]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

United States Mint


Notice of Meeting

ACTION: Notification of Citizens Coinage Advisory Committee June 29, 
2009 Public Meeting.

-----------------------------------------------------------------------

SUMMARY: Pursuant to United States Code, Title 31, section 
5135(b)(8)(C), the United States Mint announces the Citizens Coinage 
Advisory Committee (CCAC) public meeting scheduled for June 29, 2009.

DATES: June 29, 2009.
    Time: 6:30 p.m. to 9 p.m.
    Location: Gaylord Hall in the Worner Center, Campus of Colorado 
College, 902 N. Cascade Ave., Colorado Springs, CO 80903.
    Subject: Review candidate designs for the 2010 Boy Scouts of 
America Centennial Commemorative Coin Act and the United States Mint 
Director Edmund C. Moy medal.
    Interested persons should call 202-354-7502 for the latest update 
on meeting time and room location.
    In accordance with 31 U.S.C. 5135, the CCAC:
    <bullet> Advises the Secretary of the Treasury on any theme or 
design proposals relating to circulating coinage, bullion coinage, 
Congressional Gold Medals, and national and other medals.
    <bullet> Advises the Secretary of the Treasury with regard to the 
events, persons, or places to be commemorated by the issuance of 
commemorative coins in each of the five calendar years succeeding the 
year in which a commemorative coin designation is made.
    <bullet> Makes recommendations with respect to the mintage level 
for any commemorative coin recommended.

FOR FURTHER INFORMATION CONTACT: Cliff Northup, United States Mint 
Liaison to the CCAC; 801 9th Street, NW.; Washington, DC 20220; or call 
202-354-7200.
    Any member of the public interested in submitting matters for the 
CCAC's consideration is invited to submit them by fax to the following 
number: 202-756-6830.

    Authority: 31 U.S.C. 5135(b)(8)(C).

    Dated: May 22, 2009.
Edmund C. Moy,
Director, United States Mint.
[FR Doc. E9-12422 Filed 5-27-09; 8:45 am]
BILLING CODE P
<PAGE>

                                                                    EXHIBIT 31.1

                                 CERTIFICATIONS

I, Thomas C. Shull, certify that:

1.       I have reviewed this quarterly report on Form 10-Q of Hanover Direct,
Inc.;

2.       Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;

3.       Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4.       The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

         (a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

         (b) Evaluated the effectiveness of the registrant's disclosure controls
and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and

         (c) Disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's most
recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;

5.       The registrant's other certifying officers and I have disclosed, based
on our most recent evaluation of internal control over financial reporting, to
the registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):

         (a) All significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

         (b) Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's internal control
over financial reporting.

                               /s/ Thomas C. Shull
                -----------------------------------------------
                                 Thomas C. Shull
                      President and Chief Executive Officer

Date: November 10, 2003
EXHIBIT 10.2




	
	  
 Exhibit 10.2
  

	 Marriott International, Inc. Executive

	 Officer Incentive Plan and Executive
 Officer Individual Performance Plan



  
 Marriott International, Inc.
Annual Cash Incentives 
  
 To help motivate the attainment of
annual objectives, the Company maintains the Marriott International, Inc. Executive Officer Incentive Plan and the Marriott International, Inc. Executive Officer Individual Performance Plan for the Chief Executive Officer and each of the other named
executives. Under each plan, specific objectives are established annually for a minimum level, target level, and a maximum level of performance, and for each such objective, actual performance is measured against these levels in order to determine
the actual payment. 
  
 The Executive Officer Incentive Plan is
operated pursuant to the shareholder-approved Marriott International, Inc. 2002 Comprehensive Stock and Cash Incentive Plan, and is focused on rewarding participants upon the Company’s achievement of pre-established financial objectives.
Typically, the compensation committee has measured performance based upon earnings per share. Amounts payable under the Executive Officer Incentive Plan are intended to qualify as “performance-based compensation” under Section 162(m) of
the Internal Revenue Code. Notwithstanding the achievement of financial or other performance goals, the compensation committee has the authority to reduce but not increase the amount payable under the plan. 
  
 The Individual Performance Plan is focused on objectives related to one or
more measures of Company or business/operating unit financial performance, individual performance, customer satisfaction, owner and franchisee relations, lodging growth and similar objectives. Each year, the compensation committee selects the
performance criteria and weighting of the performance objectives for each eligible executive, based upon recommendations provided by senior management. These criteria and their weighting typically vary among eligible executives. 
  
 Under the plans, the aggregate target and maximum payments for the Chief
Executive Officer are 90% and 125% of salary, respectively, and other named executives may receive aggregate target and maximum payments of 60-80% and 90-110% of salary. Of these amounts, 50% to 60% are payable under the Executive Officer Incentive
Plan. No payment is made if performance fails to meet the minimum level for a particular objective. 
  

 1
### 161

OFFICE OF THE ATTORNEY GENERAL OF TEXAS

HonorableX. S. Rowe **County** Attorney,Lamb County Littlefirld,Texas

Dear Sir1

W4 aokuowl4dg4r404lpt data, and qaoto tram your 14 county i8 eonaultural Building,
from ths County Seat **nay** I ham be413**ro** your D4partmont,aa osition;Therefore will you the questionsas iollorrr

onor Court of Lamb County have let a oontraot **for th4**  **oonetruotion of**  al Building in whlah to,house the County A. A. A. Offl4e4, 4aid building to be in a town not tho County Sect of aald d would said Court hare the authorftyto Wazrante,in the 4um of $ZO,OOO.OO,in payment for **the** conatruotlon of **au4h a**  building. 2. Would the Commissioners Court of Lamb County, hato authorityto order an elootion for the eurpoao of dstermlning whether or not Bonds in the sum of 20,OOO.OO should be 144ued for the oonrrtruotion of an Agrioultural Building, in which to houa4 the County Agent, and the Trip14 A. oTfiO44; said buildingto be oonstruotedin 4 town not the County seat of said oounty.”

### I..

i Honorable El 0. Rowe, Page 2

The courts of this State hale repeatedlyheld that a oountp oannot issue bonds **unl4ss** suoh powor la ozprosslyoonferred by law. Su4h is the sstablishsddootrlno in this State, and has boon tram an early time. It was aiflrmod in the originalappeal from San'PatrioIo

County Vs. MoClane, 44 Tex. 392, and reiterated in Roblson vs. Rroedlooe,61 Tex. 316; also in L4sater vs. Lopez, 217 5. W. 376.

It is also a well establishsdrule of law in this State that a oountg subjsotto the expresssdrestriotionsimposedby the Constitutionand general laws has the impliedpower to 188~4 time warrants In payment ror improvements whioh j& is **4**

-F authorizedto oonstruot, provided the applioablercgulat on8 rolating to t~~ssuanoe oi suoh warrantsare observed. (Stratonvs. CommIssion4rs~Court 0r Kinney County, 137 5. W. 1170; Cowan st al va. Dupreo, ot al, 139 9. w. 887; Commissionors~ Court or Floyd County ot al vs. Nlohols et al, 142 S. W. 371 Iasstsr vs. Lopez, 217 s. w. 376; Adams vs. YoGIll, 146 S. W. (26) 332.)

We have railed to find a statute in this Stat4 expressly authorizinga oounty to oonstruotthe typo bulldIngmontlonsdin your request. Thoreroro,it 14 the opinion of this Department, bssed on the foregoingdooisians**of th4**  **oourts** of this .State, that 8 oounty do48 not hato **the** suthority to **issue** time warrants or bonds for the ptipose of oonstruotlng en agrioultural

building in whIoh .~\, to house the oounty agent and A. A. A. ot?iaes.

Trusting that this answers your questions,w4 are
Tory truly yours ATTORNEYQENERAL OF TEXAS

A,saistant
[Federal Register Volume 74, Number 99 (Tuesday, May 26, 2009)]
[Notices]
[Page 24860]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-12068]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

    In accordance with section 10(d) of the Federal Advisory Committee 
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care 
Policy and Research Special Emphasis Panel (SEP) meeting.
    A Special Emphasis Panel is a group of experts in fields related to 
health care research who are invited by the Agency for Healthcare 
Research and Quality (AHRQ), and agree to be available, to conduct on 
an as needed basis, scientific reviews of applications for AHRQ 
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of 
time. Rather, they are asked to participate in particular review 
meetings which require their type of expertise.
    Substantial segments of the upcoming SEP meeting listed below will 
be closed to the public in accordance with the Federal Advisory 
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 
552b(c)(6). Grant applications for the Accelerating Development of 
Methods for the Study of Complex Patients (R21) applications are to be 
reviewed and discussed at this meeting. These discussions are likely to 
reveal personal information concerning individuals associated with the 
applications. This information is exempt from mandatory disclosure 
under the above-cited statutes.

    SEP Meeting on: Accelerating Development of Methods for the 
Study of Complex Patients (R21).
    Date: June 23, 2009 (Open on June 23 from 1 p.m. to 1:15 p.m. 
and closed for the remainder of the meeting).
    Place: Agency for Healthcare Research and Quality, John 
Eisenberg Building, Conference Center, Rockville, Maryland 20850.
    Contact Person: Anyone wishing to obtain a roster of members, 
agenda or minutes of the nonconfidential portions of this meeting 
should contact Mrs. Bonnie Campbell, Committee Management Officer, 
Office of Extramural Research, Education and Priority Populations, 
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, 
Telephone (301) 427-1554.
    Agenda items for this meeting are subject to change as 
priorities dictate.

    Dated: May 15, 2009.
Carolyn M. Clancy,
Director.
[FR Doc. E9-12068 Filed 5-22-09; 8:45 am]
BILLING CODE 4160-90-M
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Child Health and Human Development Initial Review Group; Function, Integration, and Rehabilitation Sciences Subcommittee.                    

*Date:*                         June 15, 2009.                    

*Time:*                         8:30 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         The Legacy, 1775 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Anne Krey, PhD, Scientific Review Administrator, Division of Scientific Review, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, 301-435-6908.                         *ak41o@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS)

Dated: May 15, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-12193 Filed 5-26-09; 8:45 am]

BILLING CODE 4140-01-P
#### The People of the State of New York, Respondent, v Kevin Watts, Appellant.

[974 NYS2d 291]

— Application by the appellant for a writ of error coram nobis to vacate, on the ground of ineffective assistance of appellate counsel, a decision and order of this Court dated November 15, 2011 *(People v Watts,*89 *657AD3d 965 [2011]), affirming a judgment of the Supreme Court, Kings County, rendered January 5, 2010.

Ordered that the application is denied.

The appellant has failed to establish that he was denied the effective assistance of appellate counsel *(see Jones v Barnes,*463 US 745 [1983]; *People v Stultz,*2 NY3d 277 [2004]). Eng, EJ., Rivera, Dickerson and Roman, JJ., concur.